Get the Stockscreener App
8.49
4.39%
-0.39
Pre-market:
8.60
0.11
+1.30%
Teladoc Health Inc stock is traded at $8.49, with a volume of 5.85M.
It is down -4.39% in the last 24 hours and down -37.16% over the past month.
See More
Previous Close:
$8.88
Open:
$8.94
24h Volume:
5.85M
Relative Volume:
0.84
Market Cap:
$1.60B
Revenue:
$2.59B
Net Income/Loss:
$-981.73M
P/E Ratio:
-1.4714
EPS:
-5.77
Net Cash Flow:
$206.95M
1W Performance:
-9.58%
1M Performance:
-37.16%
6M Performance:
+4.94%
1Y Performance:
-43.92%
1-Day Range:
$8.48
$8.95
1-Week Range:
$8.48
$9.46
52-Week Range:
$6.76
$15.68
Teladoc Health Inc Stock (TDOC) Company Profile
Name
Teladoc Health Inc
Sector
Industry
Phone
(203) 635-2002
Address
2 MANHATTANVILLE ROAD, PURCHASE, NY
Compare TDOC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
8.49 | 1.60B | 2.59B | -981.73M | 206.95M | -5.77 |
|
VEEV
Veeva Systems Inc
|
227.80 | 36.98B | 2.75B | 714.14M | 1.09B | 4.33 |
|
SOLV
Solventum Corp
|
72.30 | 12.51B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
60.80 | 11.41B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
93.97 | 8.14B | 1.15B | 96.70M | -161.99M | 1.09 |
|
TEM
Tempus Ai Inc
|
42.16 | 7.26B | 640.44M | -743.28M | -206.93M | -11.29 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-15-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Reiterated | Jefferies | Hold |
| Feb-29-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-17-24 | Downgrade | DA Davidson | Buy → Neutral |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Feb-23-23 | Upgrade | SVB Securities | Market Perform → Outperform |
| Oct-24-22 | Upgrade | Guggenheim | Sell → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-17-22 | Downgrade | Guggenheim | Neutral → Sell |
| Aug-12-22 | Initiated | DA Davidson | Buy |
| Aug-02-22 | Downgrade | Berenberg | Buy → Hold |
| Aug-02-22 | Downgrade | Cowen | Outperform → Market Perform |
| Jul-28-22 | Downgrade | Goldman | Buy → Neutral |
| Jul-28-22 | Downgrade | Needham | Buy → Hold |
| Jul-06-22 | Reiterated | BofA Securities | Neutral |
| May-05-22 | Downgrade | Argus | Buy → Hold |
| Apr-28-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-28-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-28-22 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-28-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-28-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-28-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-03-22 | Upgrade | Argus | Hold → Buy |
| Feb-23-22 | Reiterated | BofA Securities | Neutral |
| Feb-23-22 | Reiterated | Craig Hallum | Hold |
| Feb-23-22 | Reiterated | Evercore ISI | In-line |
| Feb-23-22 | Reiterated | Goldman | Buy |
| Feb-23-22 | Reiterated | JP Morgan | Overweight |
| Feb-23-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-23-22 | Reiterated | Needham | Buy |
| Feb-23-22 | Reiterated | Oppenheimer | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-11-22 | Initiated | Goldman | Buy |
| Feb-08-22 | Reiterated | Piper Sandler | Overweight |
| Dec-02-21 | Resumed | Jefferies | Hold |
| Nov-22-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-28-21 | Reiterated | Barclays | Equal Weight |
| Oct-28-21 | Reiterated | BofA Securities | Neutral |
| Oct-28-21 | Reiterated | Canaccord Genuity | Buy |
| Oct-28-21 | Reiterated | Citigroup | Buy |
| Oct-28-21 | Reiterated | Craig Hallum | Hold |
| Oct-28-21 | Reiterated | Needham | Buy |
| Oct-28-21 | Reiterated | Oppenheimer | Outperform |
| Oct-28-21 | Reiterated | Piper Sandler | Overweight |
| Oct-28-21 | Reiterated | UBS | Neutral |
| Oct-19-21 | Initiated | Wells Fargo | Overweight |
| Aug-02-21 | Downgrade | Argus | Buy → Hold |
| Jul-28-21 | Downgrade | Deutsche Bank | Buy → Hold |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-15-21 | Initiated | Needham | Buy |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Dec-22-20 | Initiated | Evercore ISI | In-line |
| Dec-07-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Dec-04-20 | Initiated | Goldman | Neutral |
| Nov-13-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-22-20 | Initiated | DA Davidson | Buy |
| Sep-02-20 | Upgrade | Berenberg | Hold → Buy |
| Aug-17-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jul-13-20 | Initiated | Argus | Buy |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Apr-30-20 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-25-20 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-16-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-12-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-28-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-12-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-10-20 | Initiated | UBS | Neutral |
| Jan-09-20 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Teladoc Health Inc Stock (TDOC) Latest News
Teladoc Expands Specialty Care Access With Carrum Health Partnership - MSN
Teladoc's Game-Changing Partnership Solves Major Healthcare Integration Challenge for 93M Members - StockTitan
Virtual Health Service Market Projected To Witness Substantial Growth 2025-2032:Teladoc Health, Amwell, Doctor - EIN News
Teladoc Doubles Down on Connected Care With New Partnerships - Nasdaq
Cylinder joins Teladoc Health’s Connected Care Program to expand access to virtual digestive care - TradingView
Teladoc (TDOC) Advances While Market Declines: Some Information for Investors - Yahoo Finance
Teladoc partners with virtual fertility, digestive care companies - Modern Healthcare
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc.TDOC - PR Newswire
Teladoc Health Expands Connected Care Partnerships - GlobeNewswire
Teladoc Health Expands Connected Care Partnerships to Enhance Virtual Health Services Across Multiple Care Categories - Nasdaq
Teladoc Health Adds 4 Game-Changing Partners to Transform Virtual Healthcare Delivery - StockTitan
Proficio Capital Partners LLC Acquires New Stake in Teladoc Health, Inc. (NYSE:TDOC) - Defense World
Teladoc Boosts Weight Care Access With LillyDirect, Aids Growth - Yahoo Finance
Digital Therapeutics Market is expected to reach US$ 27.3 - openPR
Teladoc Health, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationTDOC - ACCESS Newswire
Teladoc Health, Inc. (NYSE:TDOC) Shares Sold by Principal Financial Group Inc. - Defense World
Teladoc Health (NYSE:TDOC) Shares Gap Down – Here’s What Happened - Defense World
Teladoc short seller attack on therapy unit highlights rise of AI - BenefitsPro
Eli Lilly Direct-To-Consumer Push Shouldn't Worry Distributors: JPMorgan - Benzinga
Teladoc Health, Inc. to Host Earnings Call - ACCESS Newswire
Teladoc Health executive sells shares worth $32,733 - Investing.com
Teladoc stock jumps on GLP-1 deal with Eli Lilly - Yahoo Finance
Truist maintains Teladoc stock Hold rating, $10 target - Investing.com
LifeMD and Teladoc Health partner with LillyDirect pharmacy provider Gifthealth for Zepbound - MSN
Teladoc partners with Eli Lilly, Burlington stock rises: Market Minute - Yahoo Finance
Truist Securities Reiterates Hold Rating on Teladoc (TDOC) - StreetInsider.com
Two telehealth firms turn to branded Zepbound as restrictions loom on copies - Reuters
Teladoc, LifeMD partner with Eli Lilly on GLP-1s - Modern Healthcare
Teladoc Health Partners With Eli Liily's LillyDirect to Expand Access to Zepbound For Weight Loss - Benzinga
Teladoc Health Provides Self-Pay Option for Eli Lilly's Obesity Drug -March 06, 2025 at 09:31 am EST - Marketscreener.com
Teladoc shares rise on partnership with LillyDirect on weight care program - Investing.com
Teladoc Health Adds GLP-1 Self-Pay Option To Comprehensive Weight Care -March 06, 2025 at 09:09 am EST - Marketscreener.com
Teladoc announces pharmacy integration agreement with Gifthealth - TipRanks
Teladoc shares rise on partnership with LillyDirect on weight care program By Investing.com - Investing.com Canada
Telehealth firms Teladoc, LifeMD tie up with Eli Lilly's pharmacy partner to offer Zepbound - TradingView
Teladoc Health Adds GLP-1 Self-Pay Option to Comprehensive Weight Care - GlobeNewswire
TDOCTeladoc Health Inc Latest Stock News & Market Updates - StockTitan
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 - GlobeNewswire
The Future of Telemedicine: $488.89 Billion Market by 2033, - openPR
Teladoc's Latest Acquisition Comes With Nearly 1M Share Compensation Package - StockTitan
Teladoc Health Enhances Prism Platform for Better Virtual Care - MSN
Avoid these Two Stocks - Baystreet.ca
Best Telemedicine Services for 2025 - CNET
Teladoc Health’s president sells $28,122 in stock By Investing.com - Investing.com South Africa
Teladoc health chief legal officer Adam Vandervoort sells $38,106 in stock - Investing.com Australia
Teladoc Health’s president sells $28,122 in stock - Investing.com India
Teladoc Health’s president of international sells $22,728 in stock - Investing.com
Teladoc Health Inc Stock (TDOC) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):